Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
Open Access
- 31 May 2018
- journal article
- research article
- Published by Korean Stroke Society in Journal of Stroke
- Vol. 20 (2) , 228-238
Abstract
Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease (SVD), which is highly prevalent in elderly individuals and a major cause of stroke and vascular cognitive impairment. Using a cross-sectional design, we studied 53 and 439 patients with genetically defined SVD (Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy [CADASIL]) and sporadic SVD, respectively, as well as 93 healthy controls. Serum NfL was measured by an ultrasensitive single-molecule array assay. We quantified magnetic resonance imaging (MRI) markers of SVD, i.e., white matter hyperintensity volume, lacune volume, brain volume, microbleed count, and mean diffusivity obtained from diffusion tensor imaging. Clinical characterization included neuropsychological testing in both SVD samples. CADASIL patients were further characterized for focal neurological deficits (National Institutes of Health stroke scale [NIHSS]) and disability (modified Rankin scale [mRS]). Serum NfL levels were elevated in both SVD samples (P2=0.52, P=1.2e-09; sporadic SVD, R2=0.21, P2=0.27, P=7.6e-05; sporadic SVD, R2=0.06, P=4.8e-08), focal neurological symptoms (CADASIL, NIHSS, P=4.2e-05) and disability (CADASIL, mRS, P=3.0e-06). We found serum NfL levels to be associated with both imaging and clinical features of SVD. Serum NfL might complement MRI markers in assessing SVD burden. Importantly, SVD needs to be considered when interpreting serum NfL levels in the context of other age-related diseases.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung (2014_A200)
- Alzheimer Forschung Initiative (16018CB)
This publication has 44 references indexed in Scilit:
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Assessment scales in stroke: clinimetric and clinical considerationsClinical Interventions in Aging, 2013
- Age-related decline in white matter tract integrity and cognitive performance: A DTI tractography and structural equation modeling studyNeurobiology of Aging, 2012
- Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocolBMC Neurology, 2011
- Diffusion Tensor Imaging and Gait in Elderly Persons With Cerebral Small Vessel DiseaseStroke, 2011
- Assessment of information processing in working memory in applied settings: the paper & pencil memory scanning testPsychological Medicine, 2007
- C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel DiseaseStroke, 2006
- Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter HyperintensitiesStroke, 2005
- Generalized Linear Model Diagnostics Using the Deviance and Single Case DeletionsJournal of the Royal Statistical Society Series C: Applied Statistics, 1987